Leadership: Page 11


  • Juliette Han WoW
    Image attribution tooltip
    Permission granted by Juliette Han Cambrian
    Image attribution tooltip
    Podcast

    Woman of the Week: Cambrian BioPharma’s Juliette Han

    The CFO and COO is advancing moonshot efforts to address aging-related diseases for the "healthspan" company and is helping emerging biotechs bring innovations out of academia.

    By Jan. 4, 2023
  • crystal ball 2023
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Opinion

    The 2023 PharmaVoice Crystal Ball: Peering into the future of life sciences

    A preview of the top trends on the minds of industry and market leaders for the new year.

    By Jan. 3, 2023
  • drug shopping cart Explore the Trendline
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Commercialization, marketing and social media

    As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical. 

    By PharmaVoice staff
  • Norman Sussman, chief medical officer, Durect
    Image attribution tooltip
    Permission granted by Durect
    Image attribution tooltip
    Profile

    Forks in the road lead one medical expert to a ‘game changing’ liver treatment

    Durect’s chief medical officer altered his retirement plans to take a leading role at the company, which is developing a treatment for severe alcohol-associated hepatitis.

    By Alexandra Pecci • Jan. 3, 2023
  • A green and yellow pointillism-style painting of a road running through a valley.
    Image attribution tooltip
    Permission granted by Jonathan Douek
    Image attribution tooltip

    From chemistry to canvas: What the pharma world can learn from art

    Art and science are often viewed as diametric opposites, but these industry insiders say their passion for painting blends into their pharma work. 

    By Karissa Waddick • Dec. 22, 2022
  • Wow year
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Opinion

    WoW: What a year

    A look back at some of the most inspirational quotes from the Women of the Week podcasts in 2022.

    By Dec. 20, 2022
  • Blood cancer
    Image attribution tooltip
    libre de droit via Getty Images
    Image attribution tooltip

    Blood cancer cures aren’t here yet — but incremental combinations bring the field closer

    A series of small successes showed promise for the future of blood cancer treatments, particularly in the arena of drug combinations.

    By Dec. 19, 2022
  • Stephen Quake, head of science, Chan Zuckerberg Initiative
    Image attribution tooltip
    Permission granted by CZI
    Image attribution tooltip
    Profile

    How one of the world’s most prolific inventors is guiding a plan to tackle all disease

    Steve Quake, science head at the Chan Zuckerberg Initiative, is leveraging personal experiences and a deep background in R&D to lead an ambitious 100-year plan.

    By Alexandra Pecci • Dec. 15, 2022
  • Vicki Goodwin Exelexis
    Image attribution tooltip
    Permission granted by Exelexis’ Dr. Vicki Goodman
    Image attribution tooltip
    Podcast

    Woman of the Week: Exelixis’ Dr. Vicki Goodman

    With several blockbuster products under her belt, veteran oncologist and drug developer Dr. Vicki Goodman is looking to further evolve Exelixis’ pipeline to address hard-to-treat cancers.

    By Dec. 14, 2022
  • Microscope blood slide
    Image attribution tooltip
    Motortion via Getty Images
    Image attribution tooltip

    At the heart of hematology breakthroughs, a community of researchers and patients comes together

    As new and advanced therapies are revealed at the annual meeting of the American Society of Hematology this week, the patients are always at the center.

    By Dec. 13, 2022
  • global health equity
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    The pharma giants making the biggest strides with global drug access

    A recent report ranks the top 20 pharma companies by how well they’re boosting a critical component of health equity.

    By Kelly Bilodeau • Dec. 12, 2022
  • An illustration of two fingers holding a crystal glass pill with a DNA strip floating inside.
    Image attribution tooltip

    Illustration: Alberto Miranda for Industry Dive

    Image attribution tooltip
    Tracker

    The 2023 PharmaVoice Year in Preview

    Here’s a look at how industry leaders are navigating the key issues of 2023.

    Dec. 12, 2022
  • A backlit Karuna Therapeutics sign on a teal wall sits behind a white marble reception desk
    Image attribution tooltip
    Permission granted by Karuna Therapeutics
    Image attribution tooltip

    With FDA filing on the horizon, Karuna appoints new CEO

    Allergan alum Bill Meury will take the helm as current CEO Steve Paul transitions to lead R&D.

    By Karissa Waddick • Dec. 9, 2022
  • Charlotte Owens, vice president, head of the Center for Health Equity and Patient Affairs, Takeda
    Image attribution tooltip
    Permission granted by Takeda
    Image attribution tooltip
    Q&A

    Takeda’s global quest for health equity

    Takeda’s Center for Health Equity and Patient Affairs is built to address health inequality around the world and aims to raise the bar for the pharma industry.

    By Dec. 8, 2022
  • A photograph of a Sarepta building in Boston, MA
    Image attribution tooltip
    Courtesy of Sarepta
    Image attribution tooltip
    Q&A

    For Duchenne-focused Sarepta, gene therapy is the natural next step

    The company with three marketed RNA drugs for Duchenne muscular dystrophy is taking the logical leap into gene therapies with a candidate under review at the FDA.

    By Dec. 8, 2022
  • Beatrice McQueen WoW image
    Image attribution tooltip
    Permission granted by Beatrice McQueen
    Image attribution tooltip
    Podcast

    Woman of the Week: Simcha Therapeutics’ Beatrice McQueen

    From sea sponges to cytokines, the chief operating officer’s career has come full circle as she pursues a new approach to treating cancer via the immune system.

    By Dec. 7, 2022
  • A man in a suit looking at the camera
    Image attribution tooltip
    Courtesy of Biogen
    Image attribution tooltip

    10 noteworthy pharma leadership shake-ups this year

    From GSK to Roche to Biogen, these were the most impactful executive changes at leading pharma companies in 2022.

    By Karissa Waddick • Dec. 7, 2022
  • lightbulb breaking
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Opinion

    Healthcare tech’s biggest busts

    The metaverse, blockchain, DCTs and more — here are some of the most recent fails in healthcare tech.

    By Dec. 2, 2022
  • pills
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    10 of our most popular articles in 2022

    Methadone, rock ‘n’ roll, clinical trial overhauls — here’s a look at our most-read stories of the year.

    By Nov. 30, 2022
  • Alison O'Neill B&W head shot
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Image attribution tooltip
    Podcast

    Woman of the Week: Surface Oncology’s Dr. Alison O’Neill

    With more than two decades of experience in oncology R&D, Dr. Alison O’Neill is helping Surface unlock the potential of next-gen immunotherapies by targeting the tumor microenvironment.

    By Nov. 30, 2022
  • A team of four people wearing white lab coats stand looking at a computer in a medical science laboratory.
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    One biotech’s approach to science-driven innovation

    Why some in the industry say fostering creativity in drug development is all about work structures.

    By Karissa Waddick • Nov. 29, 2022
  • Barry Sherman
    Image attribution tooltip

    Al Dunlop/ZUMA Press/Newscom

    Image attribution tooltip

    5 enduring mysteries of the Barry and Honey Sherman murders

    After nearly five years, the homicide case involving pharma billionaires continues to perplex investigators.

    By Nov. 28, 2022
  • A building showing a logo of Teva Pharmaceutical
    Image attribution tooltip
    Courtesy of Teva Pharmaceutical
    Image attribution tooltip

    Executive changes at Teva, Eversana could spell commercial growth in the new year

    With their latest personnel moves, these life sciences companies are preparing for major business shifts.

    By Karissa Waddick • Nov. 23, 2022
  • Nicole Lambert WoW picture
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Image attribution tooltip
    Podcast

    Woman of the Week: Myriad Genetics’ Nicole Lambert

    Empowered by her own cancer journey, Nicole Lambert is using her platform as chief operating officer of the genetic testing powerhouse to change the trajectory of care for millions of women.

    By Nov. 23, 2022
  • office red
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Opinion

    Hybrid work is here to stay — here’s how leaders should adjust

    Executives across the life sciences share their tips for navigating the new norm of remote work.

    By Nov. 18, 2022
  • Glen de Vries blue origin
    Image attribution tooltip
    Permission granted by Medidata
    Image attribution tooltip
    Q&A

    The legacy of Glen de Vries: Our last interview with the pioneering entrepreneur

    Recorded just weeks before his passing, our sit-down interview with the legendary medical sciences entrepreneur showcased his passion for pushing the industry toward its next frontier.

    By Nov. 11, 2022